PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.14%
Similar revenue growth to SUM's 4.73%. Walter Schloss would investigate if similar growth reflects similar quality.
No Data
No Data available this quarter, please select a different quarter.
-115.80%
Gross profit decline while SUM shows 7.51% growth. Joel Greenblatt would examine competitive position.
-115.03%
Margin decline while SUM shows 2.65% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-326.53%
Both companies show EBITDA decline. Martin Whitman would check industry conditions.
-315.45%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-326.53%
Operating income decline while SUM shows 8.15% growth. Joel Greenblatt would examine position.
-315.45%
Operating margin decline while SUM shows 3.27% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.11%
Tax expense reduction while SUM shows 29.92% growth. Joel Greenblatt would examine advantage.
7.11%
Net income growth while SUM declines. John Neff would investigate advantages.
1.87%
Net margin growth while SUM declines. John Neff would investigate advantages.
21407.44%
EPS change of 21407.44% while SUM is flat. Bruce Berkowitz would examine quality.
21396.67%
Diluted EPS change of 21396.67% while SUM is flat. Bruce Berkowitz would examine quality.
-100.00%
Share count reduction while SUM shows 0.05% change. Joel Greenblatt would examine strategy.
-100.00%
Diluted share reduction while SUM shows 0.09% change. Joel Greenblatt would examine strategy.